| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Sep 16, 2024 | Inhibrx Biosciences, Inc. | CEO | Buy | 90.0 | +40,000 | 4.52% | ✗ | $629.1K |
| Sep 6, 2024 | Sep 10, 2024 | Inhibrx Biosciences, Inc. | CEO | Buy | 92.5 | +44,000 | 5.23% | ✗ | $671.2K |
| Aug 29, 2024 | Sep 3, 2024 | Inhibrx Biosciences, Inc. | CEO | Buy | 90.0 | +40,000 | 4.99% | ✗ | $596.8K |
| Aug 20, 2024 | Aug 22, 2024 | Inhibrx Biosciences, Inc. | CEO | Buy | 92.5 | +40,000 | 5.25% | ✗ | $518.3K |